Related Experiment Videos
Prevention of visual field defects after macular hole surgery
The British Journal of Ophthalmology
|November 25, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized, double-blind, active-controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs. onabotulinum toxin a for subjects with moderate to severe crow's feet.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Intra-articular injection of magnesium chloride attenuates osteoarthritis progression in rats.
Osteoarthritis and cartilage·2019
Serum 25-Hydroxyvitamin D deficiency in Malaysian children with severe atopic dermatitis.
The Medical journal of Malaysia·2019
Association of glaucoma and glaucoma treatments with cataract in the UK Biobank: a cross-sectional observational study.
The British journal of ophthalmology·2026
Bacteriophage-derived ectolysin: a promising antimicrobial against fluoroquinolone-resistant MRSA.
The British journal of ophthalmology·2026
Assessing physical activity and sleep patterns in glaucoma using wearable devices.
The British journal of ophthalmology·2026
Adaptive optics imaging in bilateral vitelliform maculopathy.
The British journal of ophthalmology·2026
Topographic analysis of choroidal thickness in pachychoroid disease using ultra-widefield swept-source optical coherence tomography.
The British journal of ophthalmology·2026
Diagnostic discrepancies in glaucoma: underdiagnosis, overdiagnosis and missed opportunities in a nationwide South Korean population.
The British journal of ophthalmology·2026
The impact of renal function on pars plana vitrectomy for proliferative diabetic retinopathy and analysis of prognosis.
Retina (Philadelphia, Pa.)·2026
Prevalence and Demographic Characteristics of Cataract Among People Experiencing Homelessness: A Systematic Review.
Public health reports (Washington, D.C. : 1974)·2026
Faricimab for treatment-naïve nAMD: 1- and 2-year outcomes and PS-OCT polarimetric entropy.
International ophthalmology·2026